在特立帕肽治疗前后测量血清钙。 - Suppr

Measuring serum calcium before and after teriparatide treatment.

作者信息

Minisola S, Piemonte S, Del Fiacco R, Romagnoli E

出版信息

Osteoporos Int. 2008 Dec;19(12):1807; author reply 1809. doi: 10.1007/s00198-008-0732-x. Epub 2008 Sep 2.

DOI:10.1007/s00198-008-0732-x

PMID:18763009

Abstract

摘要

相似文献

Measuring serum calcium before and after teriparatide treatment.

Osteoporos Int. 2008 Dec;19(12):1807; author reply 1809. doi: 10.1007/s00198-008-0732-x. Epub 2008 Sep 2.

Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.

Osteoporos Int. 2008 Jul;19(7):1055-65. doi: 10.1007/s00198-007-0557-z. Epub 2008 Feb 19.

Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial.

Horm Metab Res. 2008 Apr;40(4):281-5. doi: 10.1055/s-2008-1046787. Epub 2008 Feb 15.

Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.

Endocr J. 2008 Jul;55(3):613-6. doi: 10.1507/endocrj.k07e-123. Epub 2008 Jun 3.

Changes in vitamin D metabolites during teriparatide treatment.

Bone. 2012 Jun;50(6):1368-71. doi: 10.1016/j.bone.2012.02.635. Epub 2012 Mar 9.

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

Osteoporos Int. 2007 Jan;18(1):59-68. doi: 10.1007/s00198-006-0189-8. Epub 2006 Sep 30.

Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.

J Musculoskelet Neuronal Interact. 2019 Sep 1;19(3):253-257.

No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.

Clin Endocrinol (Oxf). 2009 Apr;70(4):522-6. doi: 10.1111/j.1365-2265.2008.03342.x.

Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.

Arch Osteoporos. 2019 Jan 18;14(1):10. doi: 10.1007/s11657-019-0561-x.

Combined Pharmacologic Therapy in Postmenopausal Osteoporosis.

Endocrinol Metab Clin North Am. 2017 Mar;46(1):193-206. doi: 10.1016/j.ecl.2016.09.008. Epub 2016 Nov 28.

引用本文的文献

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis.

Ther Adv Musculoskelet Dis. 2019 Oct 5;11:1759720X19877994. doi: 10.1177/1759720X19877994. eCollection 2019.

本文引用的文献

Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.

Osteoporos Int. 2008 Jul;19(7):1055-65. doi: 10.1007/s00198-007-0557-z. Epub 2008 Feb 19.

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.

Ann Intern Med. 2007 Mar 6;146(5):326-39. doi: 10.7326/0003-4819-146-5-200703060-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Measuring serum calcium before and after teriparatide treatment.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献